patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: excerpted from "Notice to shareholders" re additional shares

excerpted from "Notice to shareholders" re additional shares

posted on May 11, 2008 06:46AM
"The Company presently has no specific plans, arrangements or understandings, either written or oral, to issue any of the additional authorized shares."
Share
New Message
Please login to post a reply